CHEMBL3908555
General
Type : Azaspiro
Chemical_Nomenclature : 3-[2-(4-fluorophenoxy)ethyl]-1,3-diazaspiro[4.5]decane-2,4-dione
Canonical SMILES : C1CCC2(CC1)C(=O)N(C(=O)N2)CCOC3=CC=C(C=C3)F
InChI : InChI=1S\/C16H19FN2O3\/c17-12-4-6-13(7-5-12)22-11-10-19-14(20)16(18-15(19)21)8-2-1-3-9-16\/h4-7H,1-3,8-11H2,(H,18,21)
InChIKey : WWRSQXLLQVERHE-UHFFFAOYSA-N
Other name(s) : 3-[2-(4-Fluoranylphenoxy)ethyl]-1,3-Diazaspiro[4.5]decane-2,4-Dione || BDBM50197679 || 7BJ
MW : 306.33
Formula : C16H19FN2O3
CAS_number :
PubChem : 4811752
UniChem : WWRSQXLLQVERHE-UHFFFAOYSA-N
Target
Families : CHEMBL3908555 ligand of proteins in family
PAF-Acetylhydrolase
Structure :
5LYY
Protein :
human-PLA2G7
References (1)
| Title : Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) - Woolford_2016_J.Med.Chem_59_10738 |
| Author(s) : Woolford AJ , Day PJ , Beneton V , Berdini V , Coyle JE , Dudit Y , Grondin P , Huet P , Lee LY , Manas ES , McMenamin RL , Murray CW , Page LW , Patel VK , Potvain F , Rich SJ , Sang Y , Somers DO , Trottet L , Wan Z , Zhang X |
| Ref : Journal of Medicinal Chemistry , 59 :10738 , 2016 |
| Abstract : |
| PubMedSearch : Woolford_2016_J.Med.Chem_59_10738 |
| PubMedID: 27933945 |
| Gene_locus related to this paper: human-PLA2G7 |